AI-powered search
AI-powered search

On-Demand CME Videos

The PA and NPs Role in Managing Atopic Dermatitis With Biologics in Clinical Practice: Online CME Activity


To learn the right answer to the following question, click "Start Activity"!

82-year-old female with a 4-month history of extremely pruritic papules and plaques with oozing and excoriations on trunk of body. Relevant past medical history of recurrent DVTs. The optimal treatment choice would be?

a. Topical steroids  
b. Oral steroids  
c. JAK Inhibitor  
d. A biologic  
e. Antibiotics with oral steroids

This activity was recorded at the 2023 Fall Clinical Dermatology Conference for PAs and NPs and is supported by an educational educational grants from LEO Pharma, Lilly, and Sanofi and Regeneron Pharmaceuticals, Inc.


In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:

Release Date:

July 18, 2023

Expiration Date:

July 18, 2024

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Overview the role of biologics for the management of moderate-to-severe atopic dermatitis

  • Identify patients who would benefit from biologics for the management of moderate-to-severe atopic dermatitis

  • Discuss how PAs and NPs can work in a multidisciplinary team to manage patients with moderate-to-severe AD on biologics

Intended Audience

This activity has been designed for dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

Christopher Bunick, MD, PhD

Associate Professor of Dermatology
Yale University School of Medicine
New Haven, CT

Lauren Miller, MPAS, PA-C

Southern Skies Dermatology & Surgery
Oxford, AL

Gil Yosopovitch

Professor, Department of Dermatology and Cutaneous Surgery

Director, Miami Itch Center 

University of Miami Miller School of Medicine

Miami, FL

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

Disclosures are as follows:

Christopher G. Bunick, MD, PhD

Grant/Research Support: Almirall

Lauren Miller, MPAS, PA-C

Consultant: Abbvie, BMS, Dermavant, EPI, Lilly, Mayne, Novartis, Sanofi Genzyme Regeneron 

Speaker's Burea: Abbvie, BMS, Dermavant, Lilly, Sanofi Genzye Regeneron

Gil Yosopovitch

Grant/Research Support: Eli Lilly, Escient, Galderma, Maruho, Pfizer, Sanofi Regeneron

Consultant: Abbvie, Arcutis,. Escient Health, Eli Lilly, Galderma, LEO Pharma, Novartis, Pfizer, Pierre Fabre, Regeneron Pharmaceuticals, Inc., Sanofi, Vifor 

Speaker's Bureau: Maruho

Intellectual Property Rights: APAP cream

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved